IL37 and inflammatory bowel disease: Aberrant expression of IL-37 has been reported in autoimmune diseases, such systemic lupus erythematosus (40), rheumatoid arthritis (41), inflammatory bowel disease (42), and psoriasis (43); however, its role in MS has not yet been documented.